KrasPharma

PJSC Kraspharma is a leading Russian pharmaceutical company headquartered in Krasnoyarsk, specializing in the development and large-scale manufacturing of hospital-sector medications. With over 65 years of experience, the company is a strategic supplier of essential medicines, including a comprehensive range of parenteral antibiotics, anti-tuberculosis drugs, and infusion solutions. Kraspharma's production facilities are modernized to meet international GMP standards, supporting its role in ensuring national pharmaceutical security. The company is actively expanding its portfolio with innovative "next-in-class" products and has recently announced strategic investments to enter advanced therapeutic areas such as CAR-T cell therapy and monoclonal antibody synthesis. Kraspharma serves markets across Russia, the CIS, and is expanding its global footprint into the Middle East and the Americas.